| Serial Number | 79348988 |
| Word Mark | MEPSGEN |
| Filing Date | Thursday, April 28, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 3, 2024 |
| Registration Number | 7490516 |
| Registration Date | Tuesday, September 3, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 18, 2024 |
| Goods and Services | Biochips for research or scientific purposes; biochip analyzing apparatus, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for inspecting biochips for laboratory use, namely, electronic biochip inspection device for testing functionality of biochips; apparatus for analyzing biochips for laboratory use, namely, electronic biochip analysis device for analyzing functionality of biochips; apparatus for manufacturing biochips for laboratory use, namely, electronic installations for the remote control of industrial biochip manufacturing operations; laboratory apparatus for analyzing biological pharmaceuticals, namely, laboratory analysis device for analyzing efficacy, potency, and toxicity evaluations of biological pharmaceuticals; microchips |
| Goods and Services | Pharmaceutical products for treating respiratory diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; stimulants for the central nervous system; pharmaceutical preparations for tumor treatment; tissue- regenerative pharmaceutical preparations; pharmaceutical preparations for use in tissue transplantation; clinical diagnostic reagents; clinical medical reagents; pharmaceuticals for the treatment of Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, Cancer, Brain disease; pharmaceutical compositions for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; pharmaceutical drugs for treating Parkinson's disease, Alzheimer's disease, Neurocognitive disorder, Neurodegenerative disease, cancer, and brain disease; cells for medical purposes; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the prevention of inflammatory disorders; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the prevention of diseases of the endocrine system; pharmaceutical products for the treatment of infectious diseases |
| Goods and Services | Wholesale store services featuring cell growth media for growing cells for use in scientific research; retail store services featuring cell growth media for growing cells for use in scientific research; wholesale store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; retail store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; wholesale store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring cardiovascular pharmaceuticals; retail store services featuring cardiovascular pharmaceuticals; wholesale store services featuring chemico-pharmaceutical preparations; retail store services featuring chemico-pharmaceutical preparations; wholesale store services featuring medical instruments; retail store services featuring medical instruments; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring biological preparations for medical or veterinary purposes; retail store services featuring biological preparations for medical or veterinary purposes; wholesale store services featuring biotechnological preparations for medical purposes; retail store services featuring biotechnological preparations for medical purposes; wholesale store services featuring biological reagents for medical purposes; retail store services featuring biological reagents for medical purposes; wholesale store services featuring biological tissue cultures for medical purposes; retail store services featuring biological tissue cultures for medical purposes; wholesale store services featuring biological preparations for medical purposes; retail store services featuring biological preparations for medical purposes; wholesale store services featuring living cells for medical purposes; retail store services featuring living cells for medical purposes; wholesale store services featuring cells for medical purposes; retail store services featuring cells for medical purposes; wholesale store services featuring cell culture instruments for medical use; retail store services featuring cell culture instruments for medical use; wholesale store services featuring cardiovascular agents for medical purposes; retail store services featuring cardiovascular agents for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring stem cells for medical purposes; retail store services featuring stem cells for medical purposes; wholesale store services featuring chemical preparations for medical purposes; retail store services featuring chemical preparations for medical purposes |
| Goods and Services | Medical diagnostic apparatus for the detection of cardiovascular diseases; medical apparatus and instruments for use in medical examination and treatment of cardiovascular diseases; cell culture instruments for medical use, namely, cell culture chambers |
| Goods and Services | Crude medicines research; drug discovery services; development of cell therapy products; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; pharmaceutical drug development; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical studies in the nature of medical and scientific research, namely, conducting clinical trials for others, and translational research and medical and scientific research; scientific research services for medical purposes in the field of cancerous diseases, CNS diseases, and brain diseases; drug delivery, medicinal effect, Biological or biotechnological research for medical products; development of biotechnology, namely, medical drug and biochip products; biotechnology research; laboratory research in the field of biology; development of biologics, namely, vaccine and therapeutic drug products; research in the field of chemistry; technological studies in the nature of biotechnology and microfluidics research; research and development of medical equipment; development of medical devices; conducting clinical trials in the field of cardiovascular disease; conducting early efficacy, potency, and toxicity evaluations in the field of new pharmaceuticals; conducting early pharmaceutical product evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testing, inspection, research of medical products; consultancy in the field of testing, inspection, and research of medical products, namely, pharmaceuticals, pharmaceutical preparations and pharmaceutical compositions; pharmaceutical product evaluation; design of devices for biological medicine analysis; development of devices for biological chemicals analysis; development of devices for biochemical chemicals; microchip design services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 9, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MEPSGEN Co., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | MEPSGEN Co., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | MEPSGEN Co., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Thursday, February 16, 2023 | ASSIGNED TO EXAMINER |
| Thursday, September 8, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 13, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 24, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, February 25, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, April 17, 2023 | REFUSAL PROCESSED BY MPU |
| Monday, April 17, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, May 10, 2023 | REFUSAL PROCESSED BY IB |
| Tuesday, October 17, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 17, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 18, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 1, 2023 | ASSIGNED TO LIE |
| Wednesday, November 1, 2023 | DATA MODIFICATION COMPLETED |
| Tuesday, November 14, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, November 14, 2023 | FINAL REFUSAL WRITTEN |
| Tuesday, November 14, 2023 | FINAL REFUSAL E-MAILED |
| Wednesday, February 14, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, February 14, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Sunday, March 3, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Monday, April 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 29, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, May 14, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Tuesday, May 14, 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
| Tuesday, May 14, 2024 | EX PARTE APPEAL-INSTITUTED |
| Thursday, May 16, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 16, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 16, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, May 16, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, May 16, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 11, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Thursday, May 16, 2024 | EXPARTE APPEAL TERMINATED |
| Wednesday, May 29, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 11, 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Tuesday, June 18, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 18, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 3, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 3, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, July 1, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 3, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Sunday, February 16, 2025 | FINAL DISPOSITION PROCESSED |
| Saturday, March 8, 2025 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, August 29, 2025 | LIMITATION OF GOODS RECEIVED FROM IB |
| Sunday, February 16, 2025 | FINAL DISPOSITION NOTICE SENT TO IB |